When will Raffles Medical (BSL.SI stock) report earnings?

Raffles Medical reports results on **23 Feb 2026**. Expect commentary on revenue, margins, and regional patient trends. The report is the main catalyst for BSL.SI stock ahead of this date.

What is the current price and valuation of BSL.SI stock?

Pre-market on 21 Feb 2026 BSL.SI stock trades at **S$1.02**. The PE is **34.33**, PB about **1.88**, and dividend yield near **2.43%**. These metrics reflect a premium to healthcare peers.

What price targets does Meyka AI give for BSL.SI stock?

Meyka AI's forecast model projects **monthly S$1.22**, **quarterly S$1.18**, and **yearly S$1.0964**. These are model outputs and not guarantees. Implied upside ranges from **7.49%** to **19.61%** versus S$1.02.

How does company debt affect BSL.SI stock outlook?

Raffles Medical has low leverage with debt to equity near **0.08**. That limits solvency risk and supports dividend capacity. Low debt is a positive factor for BSL.SI stock in a weaker macro.

SG Stocks

BSL.SI Raffles Medical (SES) S$1.02 pre-market 21 Feb 2026: earnings 23 Feb could move stock

ByHuzaifa Zahoor February 20, 2026February 20, 2026

Raffles Medical Group (BSL.SI stock) trades at S$1.02 pre-market on 21 Feb 2026, with investors eyeing earnings due 23 Feb 2026. The company shows EPS S$0.03 and a PE of 34.33, with volume at 1,412,700 shares. Ahead of results, market attention will focus on margin recovery, outpatient flows across Singapore and Greater China, and guidance that could change short-term valuation. We set a clear checklist for what to watch in the report and how it ties to price and analyst forecasts.